StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
NIOX Group Plc
LSE:NIOX.L
Sector
Location
Market Cap
USD 390.57 M
Share Price
USD 93.57
Avg Daily Volume
1,415,450
Change (1 day)
0.78%
Change (1 year)
3.50%
Change (YTD)
18.71%
NIOX Group Plc Total Liabilities for the year ending December 30, 2023: USD 9.80 M
NIOX Group Plc Total Liabilities is USD 9.80 M for the year ending December 30, 2023, a -51.17% change year over year. Total liabilities are the total amount of a company's debts and other obligations.
-
NIOX Group Plc Total Liabilities for the year ending December 30, 2022 was USD 20.06 M, a -24.18% change year over year.
-
NIOX Group Plc Total Liabilities for the year ending December 30, 2021 was USD 26.46 M, a -47.51% change year over year.
-
NIOX Group Plc Total Liabilities for the year ending December 30, 2020 was USD 50.41 M, a -76.27% change year over year.
-
NIOX Group Plc Total Liabilities for the year ending December 30, 2019 was USD 212.40 M.
Competitors
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
GE HealthCare Technologies Inc.
USD 75.13
GEHC
-1.37
-1.79%
Laboratory Corporation of America Holdings
USD 249.62
LH
-4.01
-1.58%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.30
603392.SS
-0.05
-0.62%
Globus Medical, Inc.
USD 57.12
GMED
-0.68
-1.18%
Indegene Limited
USD 6.56
INDGN.NS
-0.09
-1.40%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Danaher Corporation
USD 204.85
DHR
-0.66
-0.32%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Key Data
| Date | Total Liabilities | Shareholders' Equity | Cash and Short-Term Investments | Receivables |
|---|
Competitors
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
GE HealthCare Technologies Inc.
USD 75.13
GEHC
-1.37
-1.79%
Laboratory Corporation of America Holdings
USD 249.62
LH
-4.01
-1.58%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.30
603392.SS
-0.05
-0.62%
Globus Medical, Inc.
USD 57.12
GMED
-0.68
-1.18%
Indegene Limited
USD 6.56
INDGN.NS
-0.09
-1.40%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Danaher Corporation
USD 204.85
DHR
-0.66
-0.32%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%